Demonstration of cross-reactive antibodies to smooth gram-negative bacteria in antiserum to Escherichia coli J5.

We investigated the discrepancy between the broad cross-protection against gram-negative infections afforded by antiserum to Escherichia coli J5 and its apparently narrow cross-reactivity in vitro. Rabbits immunized with J5 bacteria produced antibodies to both the J5 lipopolysaccharide (LPS; titer by ELISA, 1:60,000) and LPS from the Re mutant of Salmonella minnesota (i.e., to the ketodeoxyoctonate [KDO] and lipid A determinants; titer, 1:3,200). In highly diluted antiserum, titers of antibody to J5 LPS were reduced by 28%-41% after adsorption with seven strains of smooth gram-negative bacteria and by only 4% after adsorption with the Re mutant. Smooth gram-negative bacteria adsorbed virtually all antibody to Re LPS. Therefore, rabbit antiserum to J5 contains type-specific antibodies to core determinants distal to KDO that can obscure highly cross-reactive antibodies to lipid A-KDO in vitro. Cross-reactive antibodies are demonstrable by adsorption with whole bacteria at limiting concentrations of antibody.

[1]  J. Verhoef,et al.  Detection of antibodies against lipopolysaccharides of Escherichia coli and Salmonella R and S strains by immunoblotting , 1985, Infection and immunity.

[2]  H. S. Warren,et al.  Cross-reactivity of rabbit antibodies to lipopolysaccharides of Escherichia coli J5 and other gram-negative bacteria. , 1985, The Journal of infectious diseases.

[3]  F. Cerra,et al.  Efficacy of type-specific and cross-reactive murine monoclonal antibodies directed against endotoxin during experimental sepsis. , 1985, Surgery.

[4]  J. McCutchan,et al.  PREVENTION OF GRAM-NEGATIVE SHOCK AND DEATH IN SURGICAL PATIENTS BY ANTIBODY TO ENDOTOXIN CORE GLYCOLIPID , 1985, The Lancet.

[5]  J. Shenep,et al.  Failure of monoclonal antibodies to core glycolipid to bind intact smooth strains of Escherichia coli. , 1985, The Journal of infectious diseases.

[6]  H. Kaplan,et al.  Protection against gram-negative bacteremia and endotoxemia with human monoclonal IgM antibodies. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[7]  M. Nelles,et al.  Mouse monoclonal antibodies reactive with J5 lipopolysaccharide exhibit extensive serological cross-reactivity with a variety of gram-negative bacteria , 1984, Infection and immunity.

[8]  R. Hancock,et al.  Monoclonal antibodies specific for Escherichia coli J5 lipopolysaccharide: cross-reaction with other gram-negative bacterial species , 1984, Infection and immunity.

[9]  T. Kirkland,et al.  An immunoprotective monoclonal antibody to lipopolysaccharide. , 1984, Journal of immunology.

[10]  L. S. Young,et al.  Enhanced survival in Pseudomonas aeruginosa septicemia associated with high levels of circulating antibody to Escherichia coli endotoxin core. , 1983, The Journal of clinical investigation.

[11]  O. Westphal,et al.  Chemistry and immunochemistry of bacterial lipopolysaccharides as cell wall antigens and endotoxins. , 1983, Progress in allergy.

[12]  W. R. Mccabe,et al.  Immunization with rough mutants of Salmonella minnesota. IV. Protection by antisera to O and rough antigens against endotoxin. , 1983, The Journal of infectious diseases.

[13]  J. McCutchan,et al.  TREATMENT OF GRAM-NEGATIVE BACTEREMIA AND SHOCK WITH HUMAN ANTISERUM TO A MUTANT ESCHERICHIA COLI , 1983 .

[14]  E. Ziegler,et al.  Induction of immunity against lethal Haemophilus influenzae type b infection by Escherichia coli core lipopolysaccharide. , 1982, The Journal of clinical investigation.

[15]  P. Jansson,et al.  Structural studies on the hexose region of the core in lipopolysaccharides from Enterobacteriaceae. , 2005, European journal of biochemistry.

[16]  J. McCutchan,et al.  Immunization against nosocomial infection. , 1981, The American journal of medicine.

[17]  E. Ziegler,et al.  Neutralization of meningococcal endotoxin by antibody to core glycolipid , 1978, The Journal of experimental medicine.

[18]  W. R. Mccabe,et al.  Immunization with R mutants of Salmonella minnesota. II. Comparison of the protective effect of immunization with lipid A and the Re mutant , 1977, Infection and immunity.

[19]  W. R. Mccabe,et al.  Immunization with R mutants of Salmonella minnesota. II. Serological response to lipid A and the lipopolysaccharide of Re mutants , 1977, Infection and immunity.

[20]  D. Strahilov,et al.  Detection by immunofluorescence of common antigenic determinants in unrelated gram-negative bacteria and their lipopolysaccharides. , 1977, The Journal of infectious diseases.

[21]  A. Nowotny,et al.  Relationship of structure to function in bacterial endotoxins: serologically cross-reactive components and their effect on protection of mice against some gram-negative infections. , 1976, Journal of general microbiology.

[22]  W. R. Mccabe,et al.  Effects of IgM and IgG antibody in patients with bacteremia due to gram-negative bacilli. , 1976, The Journal of infectious diseases.

[23]  L. S. Young,et al.  Functional role of antibody against "core" glycolipid of Enterobacteriaceae. , 1975, The Journal of clinical investigation.

[24]  L. Young,et al.  “Core” Glycolipid of Enterobacteriaceae: Immunofluorescent Detection of Antigen and Antibody 1 , 1975, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[25]  J. McCutchan,et al.  Prevention of lethal pseudomonas bacteremia with epimerase-deficient E. coli antiserum. , 1975, Transactions of the Association of American Physicians.

[26]  E. Ziegler,et al.  Human antiserum for prevention of the local shwartzman reaction and death from bacterial lipopolysaccharides. , 1973, The Journal of clinical investigation.

[27]  E. Ziegler,et al.  Treatment of E. coli and klebsiella bacteremia in agranulocytic animals with antiserum to a UDP-gal epimerase-deficient mutant. , 1973, Journal of immunology.

[28]  A. Braude,et al.  Treatment and prevention of intravascular coagulation with antiserum to endotoxin. , 1973, The Journal of infectious diseases.

[29]  W. R. Mccabe,et al.  Type-specific and cross-reactive antibodies in gram-negative bacteremia. , 1972, The New England journal of medicine.

[30]  W. R. Mccabe.  Immunization with R mutants of S. Minnesota. I. Protection against challenge with heterologous gram-negative bacilli. , 1972, Journal of immunology.

[31]  A. Braude,et al.  Passive immunization against the local Shwartzman reaction. , 1972, Journal of immunology.

[32]  C. Galanos,et al.  A new method for the extraction of R lipopolysaccharides. , 1969, European journal of biochemistry.

[33]  L. Chedid,et al.  A proposed mechanism for natural immunity to enterobacterial pathogens. , 1968, Journal of immunology.

[34]  O. Lüderitz,et al.  Über die Extraktion von Bakterien mit Phenol/Wasser , 1952 .